Dóra Haluszka

Dr. Dóra Haluszka

Semmelweis University, Budapest, Hungary
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Polymers
Verified
Journal Article
Open access
PDF file
KNKinga Dorottya Németh
Kinga Dorottya Németh
DHDóra Haluszka
Dóra Haluszka
LSLászló Seress
László Seress
BLBalint Viktor Lovasz
Balint Viktor Lovasz
József SzalmaJózsef Szalma
József Szalma
Edina LempelEdina Lempel
Edina Lempel
Air-abrasion is a popular prophylactic procedure to maintain oral hygiene. However, depending on the applied air-abrasive powder, it can damage the surface of the tooth and restorations, making it susceptible to plaque accumulation. The purpose of this study was to investigate the effect of 5 s and 10 s air-abrasion of calcium carbonate on surface roughness (Ra) of enamel, nanofill, and microhybrid resin-composites and the effect of post-polishing with two-step rubber- (RP) or one-step brush polisher (BP) to re-establish the surface smoothness. Surface topography was visualized by scanning-electron-microscopy. The quantitative measurement of the Ra was carried out with atomic-force-microscopy. Air-abrasion for 10 s decreased the Ra of enamel as a result of abrasion of the natural surface texture. Post-polishing with RP after 10 s air-abrasion did not change the Ra or BP; however, Ra was increased significantly by scratching the surface. Air-abrasion increased the Ra of resin composites significantly, irrespective of the application time. While RP provided a similarly smooth surface to the control in the case of microhybrid resin composite, BP increased the Ra significantly. The Ra for the control group of the nanofill-resin composite was initially high, which was further increased by air-abrasion. RP and BP re-established the initial Ra with deeper and shallower scratches after BP. Both the material and treatment type showed a large effect on Ra.

Verified
Journal Article
Open access
PDF file
CȘCristina M. Șulea
Cristina M. Șulea
ZMZsolt Mártonfalvi
Zsolt Mártonfalvi
CCCsilla Csányi
Csilla Csányi
DHDóra Haluszka
Dóra Haluszka
MPMiklós Pólos
Miklós Pólos
CȘCristina M. Șulea
Cristina M. Șulea
Fibrillin-1 microfibrils are essential elements of the extracellular matrix serving as a scaffold for the deposition of elastin and endowing connective tissues with tensile strength and elasticity. Mutations in the fibrillin-1 gene (FBN1) are linked to Marfan syndrome (MFS), a systemic connective tissue disorder that, besides other heterogeneous symptoms, usually manifests in life-threatening aortic complications. The aortic involvement may be explained by a dysregulation of microfibrillar function and, conceivably, alterations in the microfibrils’ supramolecular structure. Here, we present a nanoscale structural characterization of fibrillin-1 microfibrils isolated from two human aortic samples with different FBN1 gene mutations by using atomic force microscopy, and their comparison with microfibrillar assemblies purified from four non-MFS human aortic samples. Fibrillin-1 microfibrils displayed a characteristic “beads-on-a-string” appearance. The microfibrillar assemblies were investigated for bead geometry (height, length, and width), interbead region height, and periodicity. MFS fibrillin-1 microfibrils had a slightly higher mean bead height, but the bead length and width, as well as the interbead height, were significantly smaller in the MFS group. The mean periodicity varied around 50–52 nm among samples. The data suggest an overall thinner and presumably more frail structure for the MFS fibrillin-1 microfibrils, which may play a role in the development of MFS-related aortic symptomatology.

20 August 2025 in The Saudi Dental Journal
Verified
Journal Article
Open access
PDF file
KHKata Sára Haba
Kata Sára Haba
BBBulcsú Bencze
Bulcsú Bencze
GKGábor Kammerhofer
Gábor Kammerhofer
MUMárta Ujpál
Márta Ujpál
DBDorottya Bányai
Dorottya Bányai
Hamdan AlghamdiHamdan Alghamdi
Hamdan Alghamdi
Purpose: Approximately 19% of the global adult population is affected by periodontal diseases. Healing is a protracted process that is significantly influenced by the patient's motivation, proficiency, and cooperation. The prevalence of periodontal diseases in patients with diabetes mellitus is extremely high, and the relationship is bidirectional. In previous investigations, metformin (MF), a biguanide antidiabetic medicine, has demonstrated promising results when administered locally to periodontal defects. The study aimed to systematically assess available literature that evaluate the effectiveness of 1% metformin gel in the treatment of periodontal disease. We attempted to include clinical trials on patients with periodontitis treated with local administration of 1% metformin gel, compared to a placebo. Methods: Using identical MeSH terms, we conducted a systematic search in three databases. Our analysis encompassed human studies that measured the periodontal pocket depth, the clinical attachment level, and the depth of the intra-bony defect. Meta-analyses were carried out using random effects model to compare the mean differences between the study group, which received 1% MF gel locally in addition to traditional scaling and root planing (SRP), and the control group, which received a placebo in addition to conventional treatment. Results: Following the selection procedure, six articles were selected for inclusion in our meta-analysis, out of the 246 articles identified through the systematic search. After three and six months of follow-up, meta-analyses revealed statistically significant differences between the control and study groups. The overall effect for PD was a 1.33 mm reduction (95% confidence interval (CI): -1.66; -1.01) after three months and 1.87 mm (-2.24; -1.39) after six months. The overall effect of CAL was 1.80 mm (-2.26; -1.34) after three months and 2.14 mm (-2.71; -1.58) after six months. The change in IBD after a six-month follow-up was 1.16 mm (-1.40; -0.92). Conclusion: The application of 1% MF gel enhances the healing process in periodontal diseases, when employed in conjunction with conventional therapy.

27 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KHKata Sára Haba
Kata Sára Haba
PKPatrik Kreuter
Patrik Kreuter
XQXinyi Qian
Xinyi Qian
Gergely AgócsGergely Agócs
Gergely Agócs
DBDorottya Bányai
Dorottya Bányai
DVDániel Végh
Dániel Végh
Background/Objectives: As current methods of measuring blood glucose levels are inconvenient and painful for patients, using salivary glucose as a non-invasive biomarker to estimate glucose levels may improve patient compliance. This study aims to quantify the association between salivary glucose levels and blood glucose levels and to assess how heterogeneity between studies and the methodological differences affect the potential clinical use of salivary glucose. Methods: The PRISMA guidelines were used for this review, and the protocol was registered on PROSPERO (CRD42023471213). Four databases were searched: PubMed, EMBASE, Cochrane’s Library Trials, and Web of Science. The search was conducted on 22 November 2023 and updated on 18 August 2025. No filters were applied for the search. Human studies, where paired salivary and blood samples were taken both from patients with diabetes and healthy individuals after at least 8 h of fasting, were included in the analysis. We extracted correlation coefficients and group means differences. Risk of bias was assessed with QUADAS-2, and the between-study heterogeneity was examined using random-effects models. Results: Through the systematic search, 15,162 articles were found, 25 of which were included in our meta-analysis. The analysis showed a weak correlation between whole-mouth saliva samples and blood samples (r2 value: 0.05) and a slightly stronger correlation between parotid saliva samples and blood samples (r2 value: 0.11). These low r2 values reflect weak associations and are reported descriptively. The difference between the mean salivary glucose level of patients with diabetes and controls was 4.43 mg/dL (95% CI: 2.05; 6.80). The high heterogeneity (I2 values approaching 100% for mean difference analyses) limits the interpretability of pooled estimates. Conclusions: Current evidence indicates that salivary and blood glucose levels associate weakly, and the study results are highly heterogeneous. Given the weak and highly heterogeneous associations observed across studies, current evidence does not support the use of salivary glucose measurement as an alternative to blood glucose measurement for the time being. Further standardized research is required before any conclusion about clinical applicability can be drawn.

8 July 2019 in Bőrgyógyászati és Venerológiai Szemle
Verified
Journal Article
Open access
Norbert KissNorbert Kiss
Norbert Kiss
SBSzabolcs Bozsányi
Szabolcs Bozsányi
LFLuca Fésűs
Luca Fésűs
DHDóra Haluszka
Dóra Haluszka
KLKende Lőrincz
Kende Lőrincz
MMMárta Medvecz
Márta Medvecz